Am J Transplant, Volume 20, Suppl 3 Archives - Page 140 of 223 - ATC Abstracts

2020 American Transplant Congress
Implicit Bias in Recipient Selection
Y. Sweidan¹, C. Mayuga¹, B. Daly¹, K. Chavin², T. Srinivas¹, A. Padiyar¹
¹Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, ²Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: The decision to place or exclude a candidate from the waitlist is not exclusively based on medical criteria. Scant literature exists regarding the intergroup…
2020 American Transplant Congress
Outreach as a Way to Improve Access to Kidney Transplants: A Model to Align with Future of Kidney Disease Care
A. Govil¹, P. Gudsoorkar¹, C. Siemer², C. King², T. Diwan¹, E. Woodle¹, S. Shah¹, C. V. Thakar¹
¹Univ of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH
*Purpose: In 2018, there were more than 100,000 patients wait-listed for kidney transplant whereas only around 21,000 patients received a kidney transplant. Increasing access to…
2020 American Transplant Congress
Immune-Mediated Injury and Eplet Mismatches – Profiling Population-Level Interactions
H. Mohammadhassanzadeh¹, W. Zhang², W. Klement³, H. Gebel⁴, P. Keown⁵, K. Oualkacha⁶, R. Sapir-Pichhadze¹
¹Medicine, McGill University, Montreal, QC, Canada, ²McGill University, Montreal, QC, Canada, ³Organ Donation and Transplantation, Canadian Blood Services, Ottawa, ON, Canada, ⁴Emory University Hospital, Atlanta, GA, ⁵Medicine, University of British Columbia, Vancouver, BC, Canada, ⁶Université du Québec À Montréal, Montreal, QC, Canada
*Purpose: HLA genes are in linkage disequilibrium with each other. Sequence defined HLA targets (eplets) are associated with alleles and may be shared within and…
2020 American Transplant Congress
Taking it to the Max: Extremely Low LDL May Provide Benefit for Prevention of Cardiac Allograft Vasculopathy
R. Lee¹, E. J. Henricksen¹, Y. Moayedi², K. Y. Feng³, J. Han³, W. Yang⁴, R. Imai¹, J. J. Teuteberg⁴, K. K. Khush⁴
¹Pharmacy, Stanford Health Care, Stanford, CA, ²University Health Network, Toronto, ON, Canada, ³Medicine, Stanford University, Stanford, CA, ⁴Cardiac Transplant, Stanford University, Stanford, CA
*Purpose: Routine use of statins is the only Class I ISHLT recommendation in heart transplantation (HT) to reduce cardiac allograft vasculopathy (CAV) and improve survival.…
2020 American Transplant Congress
Characterization of Donor/Recipient Citizenship Status in Adult Heart Transplantation: A UNOS Registry Analysis
K. Yang¹, D. Miklin¹, J. Pizula¹, P. Genyk¹, G. Liu², A. Lee¹, S. Nuno¹, S. Hashmi¹, J. Nattiv², A. Kiankhooy³, L. Grazette², M. Fong², J. Rahman², K. Pandya², D. Vucicevic⁴, J. Li¹, P. Kingsford¹, P. Banankhah², R. Chand⁵, A. Wolfson⁶, S. Shah¹, A. Salimbangon⁷, C. Lum⁸, E. C. Depasquale², A. S. Vaidya²
¹Keck Medicine of USC, Los Angeles, CA, ²Cardiology, Keck Medicine of USC, Los Angeles, CA, ³Cardiothoracic Surgery, Keck Medicine of USC, Los Angeles, CA, ⁴Newark Beth-Israel Medical Center, Newark, NJ, ⁵Harbor-UCLA Medical Center, Torrance, CA, ⁶University of Arizona Sarver Heart Center, Tucson, AZ, ⁷UCLA Medical Center, Los Angeles, CA, ⁸The Queen's Medical Center, Honolulu, HI
*Purpose: There is a paucity of data describing heart transplant donor and recipient status. We therefore sought to examine the medical and demographic characteristics, and…
2020 American Transplant Congress
Morbidity in Lung Transplant for Connective Tissue Disease
S. Minkove¹, E. Bush², P. Shah¹
¹Pulmonary and Critical Care, Johns Hopkins, Baltimore, MD, ²Thoracic Surgery, Johns Hopkins, Baltimore, MD
*Purpose: To evaluate the post-lung transplant comorbidities of patients with connective tissue disease (CTD) compared with an age-matched cohort of patients transplanted for idiopathic pulmonary…
2020 American Transplant Congress
Chronic Lymphocytic Leukemia in a Lung Transplant Recipient
A. Arjuna¹, M. T. Olson², S. Tokman¹, S. Biswas Roy¹, M. A. Smith¹, R. M. Bremner¹, R. Walia¹
¹Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, ²University of Arizona College of Medicine - Phoenix, Phoenix, AZ
*Purpose: Malignancy is generally a contraindication to lung transplantation (LTx). Few reports describe clinical outcomes in patients undergoing solid-organ transplantation with indolent hematologic malignancy. We…
2020 American Transplant Congress
The Outcomes of Pancreas Transplantation from Pediatric Donors: A Single Center Experience
J. Choi, Y. Ko, H. Kwon, S. Shin, Y. Kim, D. Han
Division of Kidney & Pancreas Transplantation, Department of Surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: For increasing pancreas donor pool, the use of pediatric donors for pancreas transplantation is considered as a suitable option. However, the following questions still…
2020 American Transplant Congress
Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation
K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: Predictive models capable of identifying patients at risk for readmission are in development. However, it is unknown how accurate clinicians are at predicting early…
2020 American Transplant Congress
Rouleaux Formation in Human Livers During Normothermic Machine Perfusion
M. Harris¹, S. Raigani², C. Albert³, M. Reschke³, C. Carroll², J. T. Langford¹, C. Edwards⁴, D. Mulligan⁴, D. Haakinson¹, K. Uygun², H. Yeh², G. Tietjen¹
¹Division of Transplantation, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT, ²Division of Transplant Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Yale School of Engineering and Applied Science, New Haven, CT, ⁴Surgery, Division of Transplantation, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT
*Purpose: We recently discovered that red blood cells form rouleaux plugs in human kidney vasculature during normothermic machine perfusion (NMP) and are associated with poor…